Guanylate-Binding Protein 1 as a Potential Predictor of Immunotherapy: A Pan-Cancer Analysis

Background: Mainstream application of cancer immunotherapy is hampered by the low response rate of most cancer patients. A novel immunotherapeutic target or a biomarker predicting response to immunotherapy needs to be developed. Guanylate-binding protein 1 (GBP1) is an interferon (IFN)-inducible gua...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yaqi, Wu, Jie, Li, Lan, Zhang, Huibo, Zhang, Haohan, Li, Jing, Zhong, Hao, Lei, Tianyu, Jin, Yan, Xu, Bin, Song, Qibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867058/
https://www.ncbi.nlm.nih.gov/pubmed/35222540
http://dx.doi.org/10.3389/fgene.2022.820135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867058/
https://www.ncbi.nlm.nih.gov/pubmed/35222540
http://dx.doi.org/10.3389/fgene.2022.820135

Ejemplares similares